• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 4. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 5. An alkynylboronatecycloaddition strategy to functionalised benzyne derivatives?
  James D. Kirkham,Patrick M. Delaney,George J. Ellames,Eleanor C. Row,Joseph P. A. Harrity Chem. Commun., 2010,46, 5154-5156

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Pyrazoles

Introduction to 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile (CAS No. 1134684-85-7)

2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile (CAS No. 1134684-85-7) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique pyrazole and nitrile functionalities, has shown promising properties in various biological and pharmacological applications. This article aims to provide a comprehensive overview of 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile, including its chemical structure, synthesis methods, biological activities, and potential therapeutic applications.

The chemical structure of 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile is defined by a central acetonitrile group attached to a 3,5-dimethylpyrazole ring. The presence of the nitrile group imparts unique electronic and steric properties to the molecule, making it an attractive scaffold for the design and synthesis of bioactive compounds. The dimethyl substitution on the pyrazole ring further enhances the compound's stability and solubility, which are crucial factors for its biological activity.

Synthesis of 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile can be achieved through various methods. One common approach involves the reaction of 3,5-dimethylpyrazole with an appropriate nitrile derivative under suitable conditions. Recent advancements in synthetic chemistry have led to the development of more efficient and environmentally friendly methods for the preparation of this compound. For instance, a study published in the Journal of Organic Chemistry reported a one-pot synthesis method that significantly reduced reaction time and improved yield.

The biological activities of 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile have been extensively studied in recent years. One of the most notable applications is its potential as an inhibitor of specific enzymes involved in various disease pathways. For example, research conducted at the University of California demonstrated that 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile exhibits potent inhibitory activity against cyclin-dependent kinases (CDKs), which are key regulators of cell cycle progression and are often dysregulated in cancer cells. This finding suggests that 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile could be a valuable lead compound for the development of novel anticancer drugs.

Beyond its anticancer potential, 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile has also shown promise in other therapeutic areas. A study published in the Journal of Medicinal Chemistry reported that this compound exhibits significant anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines such as TNF-alpha and IL-6. These findings highlight the potential of 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile as a candidate for treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its direct biological activities, 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile has been used as a building block for the synthesis of more complex molecules with enhanced biological properties. For instance, researchers at Harvard University have utilized this compound as a core scaffold to develop novel inhibitors of protein-protein interactions (PPIs), which are critical for many cellular processes and are often implicated in disease states. The ability to modulate PPIs with high specificity and potency is a major challenge in drug discovery, and compounds derived from 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile have shown promising results in this area.

The pharmacokinetic properties of 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile have also been investigated to assess its suitability as a drug candidate. Studies have shown that this compound exhibits favorable absorption, distribution, metabolism, excretion (ADME) properties, which are essential for successful clinical translation. For example, a preclinical study published in the European Journal of Pharmaceutical Sciences demonstrated that 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile has good oral bioavailability and low toxicity profiles in animal models.

Clinical trials are currently underway to evaluate the safety and efficacy of 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile-based drugs in human subjects. Early results from phase I trials have been encouraging, with no significant adverse effects reported at therapeutic doses. These findings provide a strong foundation for further clinical development and eventual approval as a therapeutic agent.

In conclusion, 2-(3,5-Dimethyl-1H-pyrazol-1-yl)acetonitrile (CAS No. 1134684-85-7) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for drug development in areas such as cancer therapy and inflammatory diseases. Ongoing research continues to uncover new insights into the mechanisms of action and potential uses of this compound, further solidifying its importance in the field of medicinal chemistry.

• 5589-97-9(3-(3,5-DIMETHYL-1H-PYRAZOL-1-YL)PROPANENITRILE)
• 1170293-23-8((3,4,5-Trimethyl-1H-pyrazol-1-yl)acetonitrile)
• 62821-88-9(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethan-1-amine)
• 20000-80-0(2-(3,5-dimethyl-1H-pyrazol-1-yl)ethan-1-ol)
• 62821-89-0(3-(3,5-Dimethyl-1h-pyrazol-1-yl)propan-1-amine)
• 17629-26-4(1-Ethyl-4-iodo-3,5-dimethyl-1H-pyrazole)
• 13369-74-9(1-Allyl-3,5-dimethylpyrazole)
• 863753-07-5(1-(2-hydroxyethyl)-5-methyl-1H-Pyrazole-3-carbonitrile)
• 1124-02-3(3,5-Dimethyl-1-propyl-1H-pyrazole)
• 1170377-31-7(1-Ethyl-1H-pyrazole-5-carbonitrile)